List of Excipients in API cycloserine
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing cycloserine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | BENZYL ALCOHOL |
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | BUTYLPARABEN |
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | CARBOXYMETHYLCELLULOSE |
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | D&C YELLOW NO. 10 |
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | EDETATE CALCIUM DISODIUM |
Parsolex Gmp Center Inc | cycloserine | 13845-1200 | FD&C BLUE NO. 1 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for cycloserine
Excipient focus: BENZYL ALCOHOL
cycloserine drug variants containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing BENZYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLPARABEN
cycloserine drug variants containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing BUTYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE
cycloserine drug variants containing CARBOXYMETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing CARBOXYMETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
cycloserine drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE CALCIUM DISODIUM
cycloserine drug variants containing EDETATE CALCIUM DISODIUM
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing EDETATE CALCIUM DISODIUM
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
cycloserine drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
cycloserine drug variants containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
cycloserine drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
cycloserine drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
cycloserine drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
cycloserine drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
cycloserine drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
cycloserine drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PROPIONATE
cycloserine drug variants containing SODIUM PROPIONATE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing SODIUM PROPIONATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
cycloserine drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
cycloserine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Parsolex Gmp Center Inc | cycloserine | 13845-1200 |
Parsolex Gmp Center Inc | cycloserine | 13845-1201 |
Parsolex Gmp Center Inc | cycloserine | 13845-1203 |
>Company | >Ingredient | >NDC |
cycloserine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.